Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006953 · ClinicalTrials.gov registry record · NA
Bolus Versus Continuous Feeding Regimens Post Gastrostomy Tube Placement
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT02006953: Clinical Trial NA study, sponsored by University of Michigan.
NCT02006953 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 97 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02006953, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best way to feed children after they have a gastrostomy tube placed. The study compares bolus feeding to continuous feeding.
Primary Outcome
Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.
Interventions
- PROCEDURE Bolus feeding schedule following gastrostomy tube placement
- PROCEDURE Continuous chimney feeds following gastrostomy tube placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2011-08 |
| Est. Completion | 2018-11-07 |
| Phase | NA |
Why NCT02006953 stopped before completion
NCT02006953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Bolus feeding schedule following gastrostomy tube placement is the first listed.
NCT02006953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02006953 about?
NCT02006953 is a clinical study titled "Bolus Versus Continuous Feeding Regimens Post Gastrostomy Tube Placement". The purpose of this study is to determine the best way to feed children after they have a gastrostomy tube placed. The study compares bolus feeding to continuous feeding.
What is the current status of trial NCT02006953?
This trial is currently terminated. It is a NA study. The enrollment target is 97 participants. The study started on 2011-08. Estimated completion is 2018-11-07.
What interventions are being tested in trial NCT02006953?
The interventions under investigation include: Bolus feeding schedule following gastrostomy tube placement (PROCEDURE), Continuous chimney feeds following gastrostomy tube placement (PROCEDURE).
Who is sponsoring clinical trial NCT02006953?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02006953's enrollment target sits among peer trials
97 923rd of 2000 higher than 1,076 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia